SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation

被引：22

作者：

Bartels, S. ^{[1
]}

Lehmann, U. ^{[1
]}

Buesche, G. ^{[1
]}

Schlue, J. ^{[1
]}

Mozer, M. ^{[1
]}

Stadler, J. ^{[1
]}

Triviai, I. ^{[2
]}

Alchalby, H. ^{[2
]}

Kroeger, N. ^{[2
]}

Kreipe, H. ^{[1
]}

机构：

[1] Hannover Med Sch, Inst Pathol, D-30623 Hannover, Germany

[2] Univ Med Ctr, Dept Stem Cell Transplantat, Hamburg, Germany

来源：

LEUKEMIA | 2015年 / 29卷 / 01期

关键词：

MYELOPROLIFERATIVE NEOPLASMS; CALR;

D O I：

10.1038/leu.2014.277

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：253 / 255

页数：3

共 10 条

[1] Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm [J].

Beer, Philip A. ;

Delhommeau, Francois ;

LeCouedic, Jean-Pierre ;

Dawson, Mark A. ;

Chen, Edwin ;

Bareford, David ;

Kusec, Rajko ;

McMullin, Mary Frances ;

Harrison, Claire N. ;

Vannucchi, Alessandro M. ;

Vainchenker, William ;

Green, Anthony R. .

BLOOD, 2010, 115 (14) :2891-2900

[2] The genetic basis of myelodysplasia and its clinical relevance [J].

Cazzola, Mario ;

Della Porta, Matteo G. ;

Malcovati, Luca .

BLOOD, 2013, 122 (25) :4021-4034

[3] Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms [J].

Klampfl, Thorsten ;

Gisslinger, Heinz ;

Harutyunyan, Ashot S. ;

Nivarthi, Harini ;

Rumi, Elisa ;

Milosevic, Jelena D. ;

Them, Nicole C. C. ;

Berg, Tiina ;

Gisslinger, Bettina ;

Pietra, Daniela ;

Chen, Doris ;

Vladimer, Gregory I. ;

Bagienski, Klaudia ;

Milanesi, Chiara ;

Casetti, Ilaria Carola ;

Sant'Antonio, Emanuela ;

Ferretti, Virginia ;

Elena, Chiara ;

Schischlik, Fiorella ;

Cleary, Ciara ;

Six, Melanie ;

Schalling, Martin ;

Schoenegger, Andreas ;

Bock, Christoph ;

Malcovati, Luca ;

Pascutto, Cristiana ;

Superti-Furga, Giulio ;

Cazzola, Mario ;

Kralovics, Robert .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) :2379-2390

[4] Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation [J].

Kroeger, Nicolaus ;

Holler, Ernst ;

Kobbe, Guido ;

Bornhaeuser, Martin ;

Schwerdtfeger, Rainer ;

Baurmann, Herrad ;

Nagler, Arnon ;

Bethge, Wolfgang ;

Stelljes, Matthias ;

Uharek, Lutz ;

Wandt, Hannes ;

Burchert, Andreas ;

Corradini, Paolo ;

Schubert, Joerg ;

Kaufmann, Martin ;

Dreger, Peter ;

Wulf, Gerald G. ;

Einsele, Hermann ;

Zabelina, Tatjana ;

Kvasnicka, Hans Michael ;

Thiele, Juergen ;

Brand, Ronald ;

Zander, Axel R. ;

Niederwieser, Dietger ;

de Witte, Theo M. .

BLOOD, 2009, 114 (26) :5264-5270

[5] SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis [J].

Lehmann, Ulrich ;

Bartels, Stephan ;

Hasemeier, Britta ;

Geffers, Robert ;

Schlue, Jerome ;

Buesche, Guntram ;

Hussein, Kais ;

Kreipe, Hans .

BLOOD, 2013, 121 (19) :4011-4012

[6] Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2 [J].

Nangalia, J. ;

Massie, C. E. ;

Baxter, E. J. ;

Nice, F. L. ;

Gundem, G. ;

Wedge, D. C. ;

Avezov, E. ;

Li, J. ;

Kollmann, K. ;

Kent, D. G. ;

Aziz, A. ;

Godfrey, A. L. ;

Hinton, J. ;

Martincorena, I. ;

Van Loo, P. ;

Jones, A. V. ;

Guglielmelli, P. ;

Tarpey, P. ;

Harding, H. P. ;

Fitzpatrick, J. D. ;

Goudie, C. T. ;

Ortmann, C. A. ;

Loughran, S. J. ;

Raine, K. ;

Jones, D. R. ;

Butler, A. P. ;

Teague, J. W. ;

O'Meara, S. ;

McLaren, S. ;

Bianchi, M. ;

Silber, Y. ;

Dimitropoulou, D. ;

Bloxham, D. ;

Mudie, L. ;

Maddison, M. ;

Robinson, B. ;

Keohane, C. ;

Maclean, C. ;

Hill, K. ;

Orchard, K. ;

Tauro, S. ;

Du, M-Q ;

Greaves, M. ;

Bowen, D. ;

Huntly, B. J. P. ;

Harrison, C. N. ;

Cross, N. C. P. ;

Ron, D. ;

Vannucchi, A. M. ;

Papaemmanuil, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) :2391-2405

[7] Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation [J].

Panagiota, V. ;

Thol, F. ;

Markus, B. ;

Fehse, B. ;

Alchalby, H. ;

Badbaran, A. ;

Lehmannt, U. ;

Koenecke, C. ;

Shahswar, R. ;

Chaturvedi, A. ;

Stadler, M. ;

Eder, M. ;

Goehring, G. ;

Koenigsmann, M. ;

Kloos, A. ;

Trummer, A. ;

Schroeder, T. ;

Kobbe, G. ;

Thiede, C. ;

Platzbecker, U. ;

Schlegelbergers, B. ;

Kreipe, H-H ;

Ganser, A. ;

Kroeger, N. ;

Heuser, M. .

LEUKEMIA, 2014, 28 (07) :1552-1555

[8] Epigenetic inactivation of tumour suppressor gene KLF11 in myelodysplastic syndromes [J].

Potapova, Anna ;

Hasemeier, Britta ;

Roemermann, Daniel ;

Metzig, Kathleen ;

Goehring, Gudrun ;

Schlegelberger, Brigitte ;

Laenger, Florian ;

Kreipe, Hans ;

Lehmann, Ulrich .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (04) :298-303

[9] CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons [J].

Tefferi, A. ;

Lasho, T. L. ;

Finke, C. M. ;

Knudson, R. A. ;

Ketterling, R. ;

Hanson, C. H. ;

Maffioli, M. ;

Caramazza, D. ;

Passamonti, F. ;

Pardanani, A. .

LEUKEMIA, 2014, 28 (07) :1472-1477

[10] U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype [J].

Tefferi, A. ;

Finke, C. M. ;

Lasho, T. L. ;

Wassie, E. A. ;

Knudson, R. ;

Ketterling, R. P. ;

Hanson, C. A. ;

Pardanani, A. .

LEUKEMIA, 2014, 28 (02) :431-433

← 1 →